TRIP6 and cancer: Assessment from the publicly available KM Plotter database (http://kmplot.com/analysis/index.php?p=service&cancer=breast) showed that high TRIP6 expression correlated with worse RFS of breast cancer patients (Fig. 1f), which is consistent with and further validated our results.